Physician profile
Brian C Brill
NPI 1447539663
$3,402.58
in general payments reported to CMS, 2019-2025
13 companies · $2,044 in 2025
The $2,044 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.68 · 2022: $221 · 2023: $734 · 2024: $387 · 2025: $2,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,879 · Travel and Lodging: $1,201 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.02 |
| Travel and Lodging | $1,201.44 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,840.85 | 2022-2025 | Minimed 780g |
| Mannkind Corporation | $623.60 | 2023-2025 | Afrezza |
| Insulet Corporation | $265.18 | 2023-2025 | Omnipod, Omnipod |
| Lilly USA, LLC | $124.80 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $119.96 | 2022-2023 | Camzyos |
| Dexcom, INC. | $106.36 | 2023 | Dexcom G7 Gss (161) |
| Abbott Laboratories | $93.39 | 2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $81.48 | 2024 | |
| Corcept Therapeutics | $81.04 | 2023-2024 | Korlym |
| Tactile Systems Technology INC | $18.92 | 2024 | Entre Plus, Flexitouch Plus |
| Ascensia Diabetes Care US INC. | $16.67 | 2023 | |
| Novo Nordisk INC | $15.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Brill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.